# Marin Protein Hydrolysate and Metabolic Syndrome

> **NCT03807752** · NA · COMPLETED · sponsor: **Helse Møre og Romsdal HF** · enrollment: 33 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** MPH_active
- **DIETARY_SUPPLEMENT:** MPH_placebo

## Key facts

- **NCT ID:** NCT03807752
- **Lead sponsor:** Helse Møre og Romsdal HF
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-15
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-04-30
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2020-12-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03807752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03807752, "Marin Protein Hydrolysate and Metabolic Syndrome". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03807752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*